Death list: Round-up of deals that died in December
This article was originally published in Scrip
Executive Summary
While there was a flurry of new deal agreements and completed acquisitions last month, several partnerships died a death. According to Medtrack data, seven pharma/biotech agreements were terminated during December, including some that had once been flagged as potential nine- or ten-figure money-spinners.